• Home
  • Study Details
Coming Soon

Pilot study using personalized transcranial alternating current stimulation as a treatment for antenatal depression: PandA-tACS (healthy control phase)

The purpose of this study is an initial pilot study to develop the safety, feasibility, and tolerability of a new type of individualized transcranial alternating current stimulation (tACS) to treat antenatal depression, which delivers personalized stimulation waveforms based individual participant EEG activity. In the first Phase of this study, we are investigating this intervention in healthy control participants.

Age & Gender

  • 18 years ~ 45 years
  • Female

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Flavio Frohlich
Psychiatry - Research

Study Type

Clinical or Medical
Interventional

Study Topics

Behavior
Brain, Head, Nervous System
Healthy Volunteer or General Population
Mental and Emotional Health
UNC or UNC Health employees
UNC Students (undergrad, grad, professional)

IRB Number

25-0425

ClinicalTrials.gov

NCT06979154

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research